Repository logo
 
Publication

Prognostic Value of Isolated Elevated Troponin I Levels in Patients without Acute Coronary Syndrome Admitted to the Emergency Department

dc.contributor.authorDomingues, C
dc.contributor.authorFerreira, MJ
dc.contributor.authorFerreira, JM
dc.contributor.authorMarinho, AV
dc.contributor.authorAlves, PM
dc.contributor.authorFerreira, C
dc.contributor.authorFonseca, I
dc.contributor.authorGonçalves, L
dc.date.accessioned2021-05-20T14:33:47Z
dc.date.available2021-05-20T14:33:47Z
dc.date.issued2021-05
dc.description.abstractBackground: Although non-ischemic troponin elevation is frequently seen in patients admitted to the emergency department (ED), consensus regarding its management is lacking. Objectives: This study aimed to characterize patients admitted to the ED with non-ischemic troponin elevation and to identify potential mortality predictors in this population. Methods: This retrospective observational study included ED patients with a positive troponin test result between June and July of 2015. Patients with a clinical diagnosis of acute coronary syndrome (ACS) were excluded. Data on patient demographics and clinical and laboratory variables were extracted from medical records. Follow-up data were obtained for 16 months or until death occurred. The statistical significance level was 5%. Results: Troponin elevation without ACS was found in 153 ED patients. The median (IQR) patient age was 78 (19) years, 80 (52.3%) were female and 59(38.6%) died during follow-up. The median (IQR) follow-up period was 477(316) days. Survivors were significantly younger 76 (24) vs. 84 (13) years; p=0.004) and featured a higher proportion of isolated troponin elevation (without creatine kinase or myoglobin elevation) in two consecutive evaluations: 48 (53.9%) vs. 8 (17.4%), p<0.001. Survivors also presented a lower rate of antiplatelet treatment and same-day hospitalization. In the multivariate logistic regression with adjustment for significant variables in the univariate analysis, isolated troponin elevation in two consecutive evaluations showed a hazard ratio= 0.43 (95%CI 0.17-0.96, p=0.039); hospitalization, previous antiplatelet treatment and age remained independently associated with mortality. Conclusions: Isolated troponin elevation in two consecutive measurements was a strong predictor of survival in ED patients with troponin elevation but without ACS.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationArq Bras Cardiol . 2021 May;116(5):928-937.pt_PT
dc.identifier.doi10.36660/abc.20190356pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.4/2322
dc.language.isoporpt_PT
dc.peerreviewedyespt_PT
dc.subjectTroponina Ipt_PT
dc.subjectServiço de Urgência Hospitalarpt_PT
dc.subjectSíndrome Coronária Agudapt_PT
dc.subjectValor Preditivo dos Testespt_PT
dc.titlePrognostic Value of Isolated Elevated Troponin I Levels in Patients without Acute Coronary Syndrome Admitted to the Emergency Departmentpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage937pt_PT
oaire.citation.issue5pt_PT
oaire.citation.startPage928-937pt_PT
oaire.citation.titleArquivos brasileiros de cardiologiapt_PT
oaire.citation.volume116pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Prognostic Value of Isolated Elevated Troponin I Levels in Patients without Acute Coronary Syndrome Admitted to the Emergency Department.pdf
Size:
912.58 KB
Format:
Adobe Portable Document Format

Collections